Corrigendum to “Eplerenone promotes alternative activation in human monocyte-derived macrophages” (Pharmacological Reports (2017) 69(3) (592) (S1734114017300932) (10.1016/S1734-1140(13)70983-6));Eplerenone promotes alternative activation in human monocyte-derived macrophages

Pharmacological Reports

Volumn 65, Issue 1, 2013, Pages 226-234

  Łabuzek, Krzysztof ^a   Liber, Sebastian ^a   Bułdak, Łukasz ^a   Machnik, Grzegorz ^a   Liber, Justyna ^a   Okopień, Bogusław ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Aldosterone; Alternative activation; Eplerenone; Human macrophages; Mineralocorticoid receptor

Indexed keywords

ALDOSTERONE; ARGINASE 1; EPLERENONE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 4; MANNOSE RECEPTOR; MESSENGER RNA; MINERALOCORTICOID RECEPTOR; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE;

ADULT; ARTICLE; CELL ISOLATION; CELL STIMULATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EXPOSURE; DRUG MECHANISM; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; INCUBATION TIME; INFLAMMATION; MACROPHAGE; MACROPHAGE ACTIVATION; MALE; MONOCYTE DERIVED MACROPHAGE; OXIDATIVE STRESS; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN ELECTROPHORESIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 84875781156     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/j.pharep.2017.02.008     Document Type: Erratum

References (22)

1. Bradford MM: A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein dye-binding. Anal Biochem, 1976, 72, 248-251.
2. Dooley R, Harvey BJ, Thomas W.: Non-genomic actions of aldosterone: From receptors and signals to membrane targets. Mol Cell Endocrinol, 2012, 350, 223-234.
3. Flo RW, Naess A, Lund-Johansen F, Maehle BO, Sjursen H, Lehmann V, Solberg CO: Negative selection of human monocytes using magnetic particles covered by anti-lymphocyte antibodies. J Immunol Methods, 1991, 137, 69-94.
4. Fraccarollo D, Galuppo P, Schraut S, Kneitz S, van Rooijen N, Ertl G, Bauersachs J: Immediate mineralocorticoid receptor blockade improves myocardial infarct healing by modulation of the inflammatory response. Hypertension, 2008 51, 905-914.
5. Frieler RA, Meng H, Duan SZ, Berger S, Schütz G, He Y, Xi G et al.: Myeloid-specific deletion of the mineralocorticoid receptor reduces infarct volume and alters inflammation during cerebral ischemia. Stroke, 2011, 42, 179-185.
6. Gilbert KC, Brown NJ: Aldosterone and inflammation. Curr Opin Endocrinol Diabetes Obes, 2010, 17, 199-204.
7. Gordon S, Martinez FO: Alternative activation of macrophages: mechanism and functions. Immunity, 2010, 32, 593-604.
8. Guenova E, Volz T, Sauer K, Kaesler S, Müller MR, Wölbing F, Chen K et al.: IL-4-mediated fine tuning of IL-12p70 production by human DC. Eur J Immunol, 2008, 38, 3138-3149.
9. Kelly GL, Milner AE, Baldwin GS, Bell AI, Rickinson AB: Three restricted forms of Epstein-Barr virus latency counteracting apoptosis in c-myc-expressing Burkitt lymphoma cells. Proc Natl Acad Sci USA, 2006, 103, 14935-14940.
10. Kolkhof P, Borden SA: Molecular pharmacology of the mineralocorticoid receptor: Prospects for novel therapeutics. Mol Cell Endocrinol, 2012, 350, 310-317.
11. Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods, 1983, 65, 55-63.
12. Nagata D, Takahashi M, Sawai K, Tagami T, Usui T, Shimatsu A, Hirata Y et al.: Molecular mechanism of the inhibitory effect of aldosterone on endothelial NO synthase activity. Hypertension, 2006, 48, 165-171.
13. Okopień B, Kowalski J, Krysiak R, Łabuzek K, Stachura-Kułach A, Kułach A, Zieliński M, Herman ZS: Monocyte suppressing action of fenofibrate. Pharmacol Rep, 2005, 57, 367-372.
14. Pattyn F, Speleman F, De Paepe A, Vandesompele J: RTPrimerDB: the Real-Time PCR primer and probe database. Nucleic Acids Res, 2003, 31, 122-123.
15. Rice P, Longden I, Bleasby A. EMBOSS: The European Molecular Biology Open Software Suite. Trends Genet, 2000, 16, 276-277.
16. Rickard AJ, Morgan J, Tesch G, Funder JW, Fuller PJ, Young MJ: Deletion of mineralocorticoid receptors from macrophages protects against deoxycorticosterone/saltinduced cardiac fibrosis and increased blood pressure. Hypertension, 2009, 54, 537-543.
17. Rocha R, Rudolph AE, Frierdich GE, Nachowiak DA, Kekec BK, Blomme EA, McMahon EG et al: Aldosterone induces a vascular inflammatory phenotype in the rat heart. Am J Physiol Heart Circ Physiol, 2002, 283, H1802-1810.
18. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, New York, 1989, 1.25-1.28.
19. Stein M, Keshav S, Harris N, Gordon S: Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J Exp Med, 1992, 176, 287-292.
20. Stott DI: Immunoblotting and dot blotting. J Immunol Methods, 1989, 119, 153-187.
21. Towbin H, Staehelin T, Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA, 1979, 76, 4350-4354.
22. Usher MG, Duan SZ, Ivaschenko CY, Frieler RA, Berger S, Schütz G, Lumeng CN et al.: Myeloid mineralocorticoid receptor controls macrophage polarization and cardiovascular hypertrophy and remodeling in mice. J Clin Invest, 2010, 120, 3350-3364.